VCAM1 and plasma cell myeloma: Previous studies have shown that increased myeloma cells can promote their extravasation and retention in the bone marrow through interactions with endothelial interaction molecules such as VCAM1 (51), suggesting that VCAM1 plays a role in promoting cancer survival and growth in MM, consistent with our results.